205 related articles for article (PubMed ID: 17540668)
1. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance.
Metan G; Alp E; Aygen B; Sumerkan B
J Antimicrob Chemother; 2007 Jul; 60(1):197-9. PubMed ID: 17540668
[No Abstract] [Full Text] [Related]
2. Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
Metan G; Alp E; Aygen B; Sumerkan B
Int J Antimicrob Agents; 2007 Jan; 29(1):112-3. PubMed ID: 17134880
[No Abstract] [Full Text] [Related]
3. Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain.
Mugnier PD; Bindayna KM; Poirel L; Nordmann P
J Antimicrob Chemother; 2009 May; 63(5):1071-3. PubMed ID: 19252183
[No Abstract] [Full Text] [Related]
4. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Poirel L; Nordmann P
Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
[TBL] [Abstract][Full Text] [Related]
5. Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital.
Stoeva T; Higgins PG; Bojkova K; Seifert H
Clin Microbiol Infect; 2008 Jul; 14(7):723-7. PubMed ID: 18558947
[TBL] [Abstract][Full Text] [Related]
6. Carbapenem-resistant Acinetobacter baumannii infections after organ transplantation.
Reddy P; Zembower TR; Ison MG; Baker TA; Stosor V
Transpl Infect Dis; 2010 Feb; 12(1):87-93. PubMed ID: 19735384
[TBL] [Abstract][Full Text] [Related]
7. CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex.
Akers KS; Barsoumian A; Beckius ML; Murray CK; Mende K
Diagn Microbiol Infect Dis; 2010 Jun; 67(2):209-11. PubMed ID: 20466197
[No Abstract] [Full Text] [Related]
8. Endemic carbapenem-resistant Acinetobacter baumannii in a Brazilian intensive care unit.
dos Santos Saalfeld SM; Fukita Viana G; Dias Siqueira VL; Cardoso CL; Botelho Garcia L; Bronharo Tognim MC
J Hosp Infect; 2009 Aug; 72(4):365-8. PubMed ID: 19541388
[No Abstract] [Full Text] [Related]
9. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS
Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070
[No Abstract] [Full Text] [Related]
10. Carriage of OXA-58 but not of OXA-51 beta-lactamase gene correlates with carbapenem resistance in Acinetobacter baumannii.
Tsakris A; Ikonomidis A; Pournaras S; Spanakis N; Markogiannakis A
J Antimicrob Chemother; 2006 Nov; 58(5):1097-9. PubMed ID: 16997843
[No Abstract] [Full Text] [Related]
11. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
[TBL] [Abstract][Full Text] [Related]
12. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
Kopterides P; Koletsi PK; Michalopoulos A; Falagas ME
Int J Antimicrob Agents; 2007 Nov; 30(5):409-14. PubMed ID: 17851052
[TBL] [Abstract][Full Text] [Related]
13. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC
Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946
[TBL] [Abstract][Full Text] [Related]
14. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis.
Tutuncu EE; Kuscu F; Gurbuz Y; Ozturk B; Haykir A; Sencan I
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e224-6. PubMed ID: 19962335
[TBL] [Abstract][Full Text] [Related]
15. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.
Cui JC; Liu YN; Chen LA
J Antibiot (Tokyo); 2010 Jan; 63(1):29-31. PubMed ID: 19911030
[No Abstract] [Full Text] [Related]
16. Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii.
Moon C; Kwak YG; Kim BN; Kim ES; Lee CS
J Infect Chemother; 2013 Oct; 19(5):916-9. PubMed ID: 23619757
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
Rodríguez Guardado A; Blanco A; Asensi V; Pérez F; Rial JC; Pintado V; Bustillo E; Lantero M; Tenza E; Alvarez M; Maradona JA; Cartón JA
J Antimicrob Chemother; 2008 Apr; 61(4):908-13. PubMed ID: 18281693
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
Niumsup PR; Boonkerd N; Tansawai U; Tiloklurs M
Jpn J Infect Dis; 2009 Mar; 62(2):152-4. PubMed ID: 19305059
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant Acinetobacter baumannii, Russia.
Naas T; Kernbaum S; Allali S; Nordmann P
Emerg Infect Dis; 2007 Apr; 13(4):669-71. PubMed ID: 17561578
[No Abstract] [Full Text] [Related]
20. How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital.
Lu PL; Huang LY; Lian ST; Chang K; Lin CL; Hwang IJ; Chiang WG; Chen YH; Lin SF; Siu LK
Int J Antimicrob Agents; 2008 May; 31(5):463-6. PubMed ID: 18359613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
